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We investigated the effects of vitamin E supplementation on neurobehavioral alterations induced 
by chronic ingestion of lead acetate in mice. The animals were divided into three main groups, 
group 1 (control) given with normal saline (10 ml/kg) and groups 2 and 3 given with 3000 mg/kg 
lead acetate alone and in combination with 13 IU of vitamin E, respectively, for a period of 
90 days. Lead intoxication resulted in significant (P < 0.05) reduction of the number of head dips 
in the hole­board test and the time spent in the open arm of the elevated plus maze test, compared 
with the control. Intoxication also induced increased pain sensitivity, as shown by significant 
(P < 0.05) reduction in the tail flick latency and increase in the frequency of abdominal 
constrictions in the writhing test. The periods of immobility in both tail suspension and 
forced swimming tests in intoxicated animals were greater, as compared with the control. 
Co­administration of vitamin E with lead in group 3 significantly (P < 0.05) reversed all the 
mentioned shifts (increased the number of head dips and time spent in the maze open arm, 
increased the tail flick latency, decreased the frequency of writhings, and decreased the periods 
of immobility in the forced swimming and tail suspension tests). Thus, vitamin E treatment 
is capable of effectively attenuating the negative neurobehavioral consequences of lead 
intoxication.
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depression.
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INTRODUCTION
Heavy metals, in particular lead, are extensively used 
in industry, building, and everyday life; they represent 
important factors in contemporary contamination 
of the environment. Most heavy metals do not play 
known physiological roles in the organism, but their 
harmful effects are obvious.
Lead intoxication strongly influences negatively 
a variety of biological process in many organs and 
tissues; its effects on the nervous system are especially 
significant [1�. Although the use of lead in various 
spheres has at present been minimized, exposure to 
this factor still creates strong biological risks due to 
its stable presence in the environment.
Common sources of lead include some paints, 
contaminated dust, and drinking water [2�; ingestion, 
inhalation, and dermal contacts are common routes 
of exposure [3�. Children are more vulnerable to lead 
exposure due, in part, to a high rate of absorption 
after ingestion [4�; in this part of the population, lead 
intoxication induces irreversible learning and behavioral 
deficits. Thus, a search for ways of ameliorating the 
negative effects of chronic lead exposure is urgent.
Various food supplements were proposed for this 
purpose. Among them, there is β­tocopherol, a form of 
vitamin E characterized by very high antioxidant activity. 
Vitamin E is a fat­soluble vitamin found in significant 
amounts in vegetable oils, cereals, meat, poultry eggs, 
fruits, and some vegetables. This vitamin may exert some 
positive effects in diabetes [6�. A number of clinical trials 
and a smaller number of supplementation studies were 
carried out to investigate the effects of β­tocopherol 
in cardiovascular diseases, but with largely negative 
results [7�. Information on the effects of β­tocopherol in 
the case of lead toxicity is very scarce. We attempted 
to test the usefulness of vitamin E supplementation 
on neurobehavioral alterations in mice induced by 
experimental chronic lead intoxication.
METHODS
Animals. Male albino Swiss mice (20­30 g) were used 
in the study. The animals were housed and bred in the 
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pre­clinical animal house of the College of Medicine, 
University of Ibadan, Nigeria. They were kept under 
standard vivarium conditions (room temperature and 
12/12 h light­dark cycle), fed with standard mouse 
cubes (Ladokun Feeds, Nigeria), and provided with 
water ad libitum. 
The animals were randomly divided into three 
groups with six mice in each. Within the exposure 
period (90 days), mice of group I (control) received 
perorally (p.o.) normal saline (10 ml/kg), group II 
received also p.o. 3000 mg/kg of lead acetate, and 
group III received a combination of 3000 mg/kg 
of lead acetate and 13 IU vitamin E. Lead acetate 
trihydrate (Oxford Laboratory, India) was dissolved in 
drinking water. Vitamin E was obtained from a local 
pharmaceutical outfit (Ibadan, Nigeria).
Hole Board Test. The standard test was carried out 
on a wooden board (40 × 40 cm) with 16 evenly spaced 
holes, as previously described [8�. The number of head 
dips into holes within a 5­min­long observation period 
was counted. 
Elevated Plus Maze Test. The standard version of 
the test was used. The time spent by an animal during 
the observation period in the open arm of the maze 
characterized the level of anxiety. 
In all the above experiments, the arenas were 
cleaned after each test with 70% alcohol to eliminate 
olfactory bias.
Tail Withdrawal Test. A modification of the 
original tail flick test was used [10�. The animal was 
gently hand­held with a piece of towel, and a terminal 
3­cm­long segment of the tail was immersed in a water 
bath maintained at 52 ± 0.2°C. The time taken for the 
animal to flick its tail out of water was taken as the tail 
withdrawal latency. 
Acetic Acid Writhing Test. The test was carried out 
as previously described [9�. Acetic acid (0.2 ml, 3%) 
was injected i.p. to induce the characteristic writhings. 
The number of the latter occurring between the 5th and 
10th min post injection was measured.
Tail Suspension Test. The tail suspension test (TST) 
was performed according to the method described 
earlier [11�. Mice were individually suspended 60 
cm above the surface of a table with an adhesive 
tape placed 1 cm away from the tip of the tail. The 
immobility duration was recorded within the last 5 min 
during 6 min of observation. Mice were considered 
immobile only when they hung passively and were 
completely motionless.
Forced Swimming Test. A standard variant of this 
test was used. Mice were put into cold water (10 °C), 
and the period of immobility before attempts to swim 
was measured. 
RESULTS
Effects of Lead Intoxication and Its Treatment 
With Vitamin E on the Level of Anxiety. Chronic 
intoxication with lead (group 2) induced significant 
(P < 0.05) reductions in the frequency of head dips 
in the hole­board test and the duration of stay of the 
tested mice in the open arm of the elevated plus maze, 
as compared with the control group 1. In the former 
test, the difference from the control values (decrement) 
was about 47%, while in the latter test it was about 
24% (Fig. 1A, B). When peroral introduction of lead 
acetate was combined with administration of vitamin 
E (group 3, lead + vitamin E), these negative effects 
were neutralized, and the respective indices (numbers 
of head dips and time spent for exploration of the 
open arm) even somewhat (insignificantly, P > 0.05) 
exceeded the control data. At the same time, these 
values in group 3 significantly (P < 0.05) exceeded the 
respective values in group 2 (lead alone) (Fig. 1A, B). 
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F i g. 1. Effects of lead and vitamin E on the indices characterizing 
the anxiety level. A) Number of head dips in the hole­board test; 
B) time, sec, spent in the open arm of the elevated plus maze. Groups 
1­3 are the control, treated with lead acetate alone, and treated with 
lead acetate + vitamin E, respectively. Means ± s.e.m are shown, 
n = 6 in each group. *P < 0.05 compared with the control (group 1); 
#P < 0.05 compared with group 2.
Р и с. 1. Впливи свинцю та вітаміну Е на показники, що харак­
теризують рівень тривожності. 
NEUROPHYSIOLOGY / НЕЙРОФИЗИОЛОГИЯ.—2015.—T. 47, № 3 297
NEUROBEHAVIORAL CONSEQUENCES OF CHRONIC LEAD INTOXICATION
Effects of lead intoxication and its treatment 
with vitamin E on the results of the open field 
test. Chronic lead intoxication noticeably suppressed 
locomotion activities (mean number of crossed 
squares) in the above test; the respective index in 
group 2 was only 76% of that in the control group 1. 
The treatment with vitamin E neutralized this negative 
shift, and locomotor activity in group 3 was even more 
intense than in the control (Fig. 2). Lead intoxication 
also significantly suppressed orientation/research 
activity of mice (number of stands) and grooming 
activity. The treatment with vitamin E in group 3 
provided considerable correction effects on the 
respective indices. 
Effects of lead intoxication and its treatment 
with vitamin E on the pain sensitivity. Lead­
intoxicated mice demonstrated increased sensitivity 
to thermal pain stimulation in the tail­flick test. The 
mean latency of the tail­flick reaction in group 2 was 
equal to 47% of that in the control group (P < 0.05, 
Fig. 3A). The sensitivity of animals with respect to 
chemically induced visceral pain in the writhing test 
was also significantly higher than that in the control; 
the increment in the mean number of writhings was 
about 31% (P < 0.05, Fig. 3B). Parallel treatment 
of intoxicated mice with vitamin E completely 
neutralized negative consequences of lead intoxication 
(in comparison of group 3 with group 2, P < 0.05 in 
both tests) and even provided rather intense analgesic 
effects, as compared with the control group 1 
(Fig. 3A, B). 
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F i g. 2. Mean values of the locomotion activities observed in the 
open field test in the control and treated groups. Designations are 
the same as in Fig. 1. 
Р и с. 2. Середні індекси локомоторної активності в тесті від­
кри того поля у мишей контрольної та експериментальної груп. 
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Effects of lead intoxication and its treatment 
with vitamin E on the depression-related indices. 
In group 2 (administration of lead acetate alone), the 
average period of immobility in the tail suspension 
test was 16% longer than that in the control group 1 
(P < 0.05). The treatment of lead­intoxicated mice with 
vitamin E (group 3) significantly (P < 0.05) decreased 
F i g. 3. Effects of lead and vitamin E on the sensitivity to pain. A) 
Tail flick latency, sec; B) number of writhings within the observation 
period. Designations are the same as in Figs. 1 and 2. 
Р и с. 3. Впливи свинцю та вітаміну Е на чутливість до болю.
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F i g. 4. Effects of lead and vitamin E on the indices characterizing 
the level of depression. A) Period of immobility, sec, in the 
tail suspension test, sec; B) that in the forced swimming test. 
Designations are the same as in Figs. 1­3. 
Р и с. 4. Впливи свинцю та вітаміну Е на показники, що 
характеризують рівень депресії. 
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the respective time interval, as compared with that 
in group 2 (Fig. 4A). Nearly the same situation was 
observed in the force swimming test. The mean period 
of immobility in group­2 mice exceeded by 32% 
the corresponding index in control mice (group 1). 
A quite comparable decrease in this index related to 
introduction of vitamin E was observed in group 3 
compared with group 2 (Fig. 4B). 
DISCUSSION
In our study, we examined the effects of chronic 
lead intoxication (peroral introduction) on a few 
neurobehavioral indices in mice and the effects of 
treatment with vitamin E on the respective alterations. 
The results obtained demonstrated a clear ability of 
vitamin E (in the doses tested) to reverse negative 
behavioral changes induced by chronic lead ingestion.
Lead intoxication resulted in a clear increase in 
the level of anxiety in tested animals. Manifestations 
of orientation/research activity (characterized by the 
number of muzzle dips in the openings of the hole­
board plate and time spent in the open arm of the 
elevated plus maze) in lead­intoxicated mice were 
noticeably smaller than the respective values in the 
control. These shifts toward greater values of anxiety 
in group­2 mice were effectively neutralized by 
accompanying treatment with vitamin E in group 3. 
Ingestion of large amounts of lead also resulted 
in the development of noticeable hyperalgesia in 
experimental mice of group 2. This was demonstrated 
by an about twofold drop of the tail flick latency 
(thermally evoked somatic pain) and a noticeable 
increase in the intensity of writhings in the respective 
test (chemically induced visceral pain). These negative 
shifts were removed by the treatment with vitamin E, 
and even relative hypoalgesia was observed in group­3 
mice in both above­mentioned tests. 
Quite comparable results were obtained in the tail 
suspension and forced swimming tests. In both tests, 
the initial periods of immobility (which is usually 
interpreted as an index of the depression level) were 
in lead­intoxicated mice noticeably longer than those 
in the control. Again, these negative shifts could be 
effectively removed by the E vitamin treatment. 
Thus, chronic lead intoxication provides clear 
anxiogenic and depressive effects and increases in 
the sensitivity to somatic and visceral pain. Co­
administration of vitamin E effectively removed the 
negative effects of lead. The orientation/research 
activity of the intoxicated mice is intensified, 
locomotor activity in the open field test increased, and 
hyperalgesia in group­2 mice is replaced by relative 
hypoalgesia in group­3 animals. In other words, 
vitamin E is a rather effective means for amelioration 
of negative behavioral effects of lead intoxication. 
Antioxidants, in general, have been shown to inhibit 
apoptosis [2�, a mechanism supposed to contribute to 
the development of lead neurotoxicity. Since vitamin 
E is a powerful antioxidant, this mechanism might in 
part be responsible for amelioration of the respective 
neurotoxic effect.
Oxidative damage was shown to be associated with 
the molecular mechanism of lead poisoning [12�. 
Lead is capable of easily penetrating the blood­brain 
barrier, thereby making the brain easily susceptible 
to free­radical damage and, hence, oxidative 
stress. Our data convincingly demonstrate that lead 
neurotoxicity is due, to a considerable extent, to 
the development of such stress because vitamin E, 
as a powerful antioxidant, effectively removes the 
respective negative neurobehavioral shifts. No doubt, 
other mechanisms of lead intoxication and effects 
counteracting this intoxication cannot be ruled out and 
should be examined in the future.
In conclusion, our study demonstrated that 
vitamin E, when co­administered with lead acetate, 
significantly reversed negative neurobehavioral 
alterations induced by chronic lead ingestion. This 
vitamin, therefore, might be of clinical importance in 
the management of lead poisoning.
All experimental protocols were in agreement with the 
internationally accepted ethical norms and with the guidelines 
of the Ethics Committe of the College of Medicine, University 
of Ibadan, Nigeria.
The authors of this study, G. F. Ibironke and S. T. Adu, confirm 
that the research and publication of the results were not 
associated with any conflicts regarding commercial or financial 
relations, relations with organizations and/or individuals who 
may have been related to the study, and interrelations of co­
authors of the article.
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НЕЙРОПОВЕДІНКОВІ НАСЛІДКИ ХРОНІЧНОГО 
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(Нігерія).
Р е з ю м е
Ми досліджували зміни нейроповедінкових показників у 
мишей, викликані хронічним пероральним уведенням аце­
тату свинцю, та корекцію цих змін за допомогою вітаміну 
Е. Тварини були поділені на три групи: контрольну групу 1, 
що отримувала фізіологічний розчин (10 мл/кг), та групи 
2 і 3, котрим протягом 90 діб уводили 3000 мг/кг ацетату 
свинцю ізольовано або в комбінації з 13 М.О. вітаміну Е 
відповідно. Свинцева інтоксикація зумовлювала істотне 
(P < 0.05) зменшення кількості зазирань в отвори під час 
проходження тесту «отвори в дошці» та часу, проведеного 
у відкритих рукавах «підвищеного» лабіринту. Інтоксика­
ція також призводила до підвищення чутливості до болю, 
про що свідчили істотні скорочення латентного періоду від­
смикування хвоста та збільшення кількості «корчів», інду­
кованих уведенням оцтової кислоти, у відповідних тестах. 
Періоди нерухомості у тестах підвішування за хвіст та при­
мусового плавання в інтоксикованих тварин були довши­
ми, ніж у контролі. Паралельне уведення вітаміну Е тва­
ринам групи 3 істотно (P < 0.05) нейтралізувало вказані 
негативні зрушення. Ставали більшими число зазирань в 
отвори та час, проведений у відкритих рукавах лабіринту; 
латентний період відсмикування хвоста подовжувався, а 
число «корчів» зменшувалося; періоди імобілізації у зга­
даних вище тестах скорочувалися. Отже, вітамін Е, будучи 
потужним антиоксидантом, ефективно згладжує негативні 
нейроповедінкові наслідки свинцевої інтоксикації. 
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